| Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity L Cantuti-Castelvetri, R Ojha, LD Pedro, M Djannatian, J Franz, ... Science 370 (6518), 856-860, 2020 | 2003 | 2020 |
| SARS-CoV-2 requires acidic pH to infect cells AJB Kreutzberger, A Sanyal, A Saminathan, LM Bloyet, S Stumpf, Z Liu, ... Proceedings of the National Academy of Sciences 119 (38), e2209514119, 2022 | 92 | 2022 |
| Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease AJB Kreutzberger, A Sanyal, R Ojha, JD Pyle, O Vapalahti, G Balistreri, ... Journal of virology 95 (21), 10.1128/jvi. 00975-21, 2021 | 40 | 2021 |
| Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein K Yang, C Wang, AJB Kreutzberger, R Ojha, S Kuivanen, S Couoh-Cardel, ... Proceedings of the National Academy of Sciences 119 (40), e2210990119, 2022 | 34 | 2022 |
| SARS-CoV-2 infection of human neurons is TMPRSS2 independent, requires endosomal cell entry, and can be blocked by inhibitors of host phosphoinositol-5 kinase P Kettunen, A Lesnikova, N Räsänen, R Ojha, L Palmunen, M Laakso, ... Journal of Virology 97 (4), e00144-23, 2023 | 23 | 2023 |
| Fermentation of municipal solid wastes by bacterial isolates for production of raw protein degrading proteases AK Azad, A Nahar, MM Hasan, K Islam, MF Azim, MS Hossain, ... Asian J. Microbiol. Biotechnol. Environ. Sci 15, 365-374, 2013 | 22 | 2013 |
| Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation A Serra, M Fratello, A Federico, R Ojha, R Provenzani, E Tasnadi, ... Briefings in Bioinformatics 23 (1), 1-20, 2021 | 21 | 2021 |
| Screening of antibiotic resistant gram negative bacteria and plasmid profiling of multi-drug resistant isolates present in sewage associated with health care centers KMA Ashfaq, S Pijush, IM Majharul, OR Kant, BG Chandra International Journal of Medical Research & Health Sciences 2 (4), 923-930, 2013 | 11 | 2013 |
| Human-derived air–liquid interface cultures decipher Alzheimer’s disease–SARS-CoV-2 crosstalk in the olfactory mucosa MA Shahbaz, S Kuivanen, R Lampinen, L Mussalo, T Hron, T Závodná, ... Journal of Neuroinflammation 20 (1), 299, 2023 | 8 | 2023 |
| Vemurafenib Inhibits Acute and Chronic Enterovirus Infection by Affecting Cellular Kinase Phosphatidylinositol 4-Kinase Type IIIβ M Laajala, M Zwaagstra, M Martikainen, MP Nekoua, M Benkahla, F Sane, ... Microbiology spectrum 11 (4), e00552-23, 2023 | 3 | 2023 |
| Complete protection from SARS-CoV-2 lung infection in mice through combined intranasal delivery of PIKfyve kinase and TMPRSS2 protease inhibitors R Kant, L Kareinen, R Ojha, T Strandin, SH Saber, A Lesnikova, ... bioRxiv, 2023 | 3 | 2023 |
| Computational study of SnRK2 in Arabidopsis thaliana: An in silico approach for homology modeling and functional characterization of SRK2G/SnRK2. MS Sultana, RK Ojha, MM Islam, MA Ashfaq, KF Khan, P Sutradhar International Journal of Computational Bioinformatics and In Silico Modeling …, 2013 | 2 | 2013 |
| Dynamin independent endocytosis is an alternative cell entry mechanism for multiple animal viruses R Ojha, A Jiang, E Mäntylä, T Quirin, N Modhira, R Witte, A Gaudin, ... PLoS Pathogens 20 (11), e1012690, 2024 | 1 | 2024 |
| Inhibition of host N-myristoylation compromises the infectivity of SARS-CoV-2 due to Golgi-bypassing egress from lysosomes and endoplasmic reticulum SH Saber, MR Shaker, J Sng, N Yak, SD Morrison, S Pars, H Zheng, ... bioRxiv, 2023.03. 03.530798, 2023 | 1 | 2023 |
| Structure Prediction and Functional Characterization of Some Hypothetical Proteins of Oryza Sativa RK Ojha, AK Shah, RK Mandal Biomirror 4 (9), 2013 | 1 | 2013 |
| SARS-CoV-2 entry mechanisms and antiviral strategies RK Ojha Helsingin yliopisto, 2024 | | 2024 |
| SARS-CoV-2 infection in hiPSC-derived neurons is cathepsin-dependent and causes accumulation of HIF1alpha and phosphorylated tau P Kettunen, janika ruuska, T Quirin, R Ojha, SH Saber, M Shaker, ... bioRxiv, 2024.11. 21.624622, 2024 | | 2024 |
| Alternative cell entry mechanisms for SARS-CoV-2 and multiple animal viruses R Ojha, A Jiang, E Mäntylä, N Modhira, R Witte, A Gaudin, L De Zanetti, ... bioRxiv, 2023.07. 02.547368, 2023 | | 2023 |
| Drug discovery targeting SARS-CoV-2 membrane fusion K Yang, C Wang, AJB Kreutzberger, R Ojha, S Kuivanen, S Couoh-Cardel, ... Biophysical Journal 122 (3), 322a, 2023 | | 2023 |
| Tracking infectious entry routes of SARS-CoV-2 LM Bloyet, S Stumpf, Z Liu, R Ojha, MT Patjas, A Geneid, CA Doyle, ... | | 2022 |